Feedback / Questions
gemcitabine/docetaxel controlled release (NDV-01) - Relmada Therapeutics
https://www.manilatimes.net/2025/12/03/tmt-newswire/globenewswire/relmada-therapeutics-announces-presentation-of-ndv-01-phase-2-data-at-the-society-for-urologic-oncology/2236155
Dec 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next